- Breakthrough in fight against world’s deadliest cancer – new drug shrunk up to 70% of pancreatic tumors in lab Daily Mail
- Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy Nature.com
- Investigational therapeutic shows promise in preclinical pancreatic cancer model Medical Xpress
- New treatment for pancreatic cancer patients now available in the Upstate WSPA 7News
- Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins GlobeNewswire
Read original article here